Virologically suppressed people with HIV were eligible to enroll in the study if their current ART regimen contained one or more pills per day, boosters, or drugs with cumulative toxicity ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Whilst some antiretroviral drugs ... that HIV infection itself could cause metabolic disturbances, including dyslipidemia and diabetes mellitus. In comparison to untreated patients, regimens ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

Three years after the discovery of the human immunodeficiency virus (HIV) in 1984, GlaxoSmithKline's (GSK's) Retrovir (zidovudine) became the first drug to be approved for the treatment of this ...

The antiretroviral drug has been hailed as a potential ... generics companies will be able to make a lower-cost version of the HIV prevention regimen, subject to regulatory approvals, in 120 ...

Although more work needs to be done, Irvine and others hope to bring this two-dose regimen to the clinic. Irivine and his team for the first time, optimized vaccine dose that overcomes HIV mutation ...

Maharashtra launches a groundbreaking 28-day TB treatment for HIV patients aiming to reduce mortality and improve healthcare ...

Achieving this is generally the goal of HIV treatment, and it can be reached through any number of drug regimens. If your partner stays on top of their treatment schedule and HIV in their blood ...

A new study published in the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases showed that two ...

Whilst some antiretroviral drugs ... that HIV infection itself could cause metabolic disturbances, including dyslipidemia and diabetes mellitus. In comparison to untreated patients, regimens ...